STOCK TITAN

Chemours Co (NYSE: CC) CFO purchases 3,350 shares in open-market trade

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Chemours Co Chief Financial Officer Shane Hostetter purchased common stock in a personal transaction. On 2026-08-06, he bought 3,350 shares of Chemours common stock at $14.94 per share. Following this purchase, he directly and beneficially owned a total of 102,697.7058 shares, which includes directly owned shares, restricted stock units, and dividend equivalent units.

Positive

  • None.

Negative

  • None.
Insider HOSTETTER SHANE
Role Chief Financial Officer
Bought 3,350 shs ($50K)
Type Security Shares Price Value
Purchase Common Stock F1 3,350 $14.94 $50K
Holdings After Transaction: Common Stock — 102,697.7058 shares (Direct)
Footnotes (1)
  1. F1. Includes directly owned shares, restricted stock units and dividend equivalent units.
Shares purchased 3,350 shares Common stock acquired on 2026-08-06 by CFO Shane Hostetter
Purchase price $14.94 per share Price paid for Chemours common stock on 2026-08-06
Post-transaction holdings 102,697.7058 shares Total beneficial ownership after the transaction, including RSUs and dividend equivalent units
restricted stock units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend equivalent units financial
"Includes directly owned shares, restricted stock units and dividend equivalent units."
Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.
open market or private transaction financial
"transaction_code_description: Purchase in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Chemours Co (CC) report for Shane Hostetter?

Chemours Co reported that CFO Shane Hostetter purchased 3,350 shares of common stock on 2026-08-06. The shares were acquired at $14.94 per share in an open market or private transaction.

How many Chemours Co (CC) shares does Shane Hostetter own after this Form 4 transaction?

After the reported purchase, Shane Hostetter beneficially owned 102,697.7058 Chemours shares. This total includes directly owned shares, restricted stock units and dividend equivalent units as described in the filing footnote.

Was the Chemours Co (CC) CFO’s August 2026 trade a buy or a sell?

The August 6, 2026 trade by Chemours CFO Shane Hostetter was a purchase of common stock. The filing classifies the transaction under code P, a buy in an open market or private transaction.

What price did the Chemours Co (CC) CFO pay per share in this Form 4?

Shane Hostetter paid $14.94 per share for 3,350 Chemours common shares. The transaction price is reported on a per-share basis and reflects an open market or private purchase.

Does the Chemours Co (CC) Form 4 mention Rule 10b5-1 trading plan use?

The Form 4 indicates the Rule 10b5-1 checkbox is not selected. This means the reported August 6, 2026 purchase was not affirmed as made under a Rule 10b5-1 trading plan in the form’s checkbox.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOSTETTER SHANE

(Last)(First)(Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET

(Street)
WILMINGTON DELAWARE 19801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/06/2026P3,350A$14.94102,697.7058(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes directly owned shares, restricted stock units and dividend equivalent units.
/s/ Eric Stein, Attorney-in-Fact08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)